A framework for stakeholder engagement in the adoption of new anti-malarial treatments in Africa: a case study of Nigeria
Background Recent reports of artemisinin partial resistance from Rwanda and Uganda are
worrisome and suggest a future policy change to adopt new anti-malarials. This is a case …
worrisome and suggest a future policy change to adopt new anti-malarials. This is a case …
Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: an analysis of stakeholders' perspectives in Burkina Faso and Nigeria
P Tindana, R Guissou, OA Bolarinwa, F Tou… - PLoS …, 2022 - journals.plos.org
Background Artemisinin-based combination therapies (ACTs) are the recommended
treatment for uncomplicated Plasmodium falciparum malaria in all malaria endemic …
treatment for uncomplicated Plasmodium falciparum malaria in all malaria endemic …
[HTML][HTML] Ethical, Regulatory and Market related aspects of Deploying Triple Artemisinin-Based Combination Therapies for Malaria treatment in Africa: A study protocol.
P Tindana, F de Haan, OA Mokuolu… - Wellcome open …, 2021 - ncbi.nlm.nih.gov
Abstract Introduction: According to the World Malaria Report 2019, Africa accounts for 94%
of the global malaria deaths. While malaria prevalence and mortality have declined over the …
of the global malaria deaths. While malaria prevalence and mortality have declined over the …
Awareness of antimalaria policy and use of Artemisinin-based combination therapy for malaria treatment in communities of two selected local government areas of …
With limited data on the awareness of change in the use of antimalaria drugs and availability
and use of artemisinin-based combination therapy (ACT) in the context of the Roll Back …
and use of artemisinin-based combination therapy (ACT) in the context of the Roll Back …
Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug
GM Mubyazi, MA Gonzalez-Block - Malaria Journal, 2005 - Springer
Introduction Research is an essential tool in facing the challenges of scaling up
interventions and improving access to services. As in many other countries, the translation of …
interventions and improving access to services. As in many other countries, the translation of …
To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?
F De Haan, OA Bolarinwa, R Guissou, F Tou… - PLoS …, 2021 - journals.plos.org
Introduction Triple artemisinin-based combination therapies (TACTs) are being developed
as a response to artemisinin and partner drug resistance in the treatment of falciparum …
as a response to artemisinin and partner drug resistance in the treatment of falciparum …
Putting the genie back in the bottle? Availability and presentation of oral artemisinin compounds at retail pharmacies in urban Dar-es-Salaam
Background Recently global health advocates have called for the introduction of artemisinin-
containing antimalarial combination therapies to help curb the impact of drug-resistant …
containing antimalarial combination therapies to help curb the impact of drug-resistant …
Knowledge and malaria treatment practices using artemisinin combination therapy (ACT) in Malawi: survey of health professionals
LV Kalilani-Phiri, D Lungu, R Coghlan - Malaria journal, 2011 - Springer
Background Malaria still remains a life-threatening disease worldwide causing between 190
and 311 million cases of malaria in 2008. Due to increased resistance to sulphadoxine …
and 311 million cases of malaria in 2008. Due to increased resistance to sulphadoxine …
Experiences of healthcare personnel on the efficacy of artemisinin-based combination therapy and malaria diagnosis in hospitals in Uganda
M Ocan, R Bakubi, M Tayebwa, J Basemera, S Nsobya - Malaria Journal, 2023 - Springer
Background The risk of widespread resistance to artemisinin-based combination therapy
(ACT) remains high in Uganda following detection of Plasmodium falciparum parasites with …
(ACT) remains high in Uganda following detection of Plasmodium falciparum parasites with …
Time to scale up molecular surveillance for anti-malarial drug resistance in sub-saharan Africa
C Nsanzabana - Malaria Journal, 2021 - Springer
Artemisinin resistance has emerged and spread in the Greater Mekong Sub-region (GMS),
followed by artemisinin-based combination therapy failure, due to both artemisinin and …
followed by artemisinin-based combination therapy failure, due to both artemisinin and …